Effectiveness of aprepitant in post‐acute COVID19 syndrome

This is the first case of a patient taking aprepitant for a post‐acute COVID‐19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.

Detalles Bibliográficos
Autores principales: Reinoso‐Arija, Rocío, López‐Ramírez, Cecilia, Jimenez‐Ruiz, José Antonio, López‐Campos, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449093/
https://www.ncbi.nlm.nih.gov/pubmed/34567551
http://dx.doi.org/10.1002/ccr3.4646
_version_ 1784569360700932096
author Reinoso‐Arija, Rocío
López‐Ramírez, Cecilia
Jimenez‐Ruiz, José Antonio
López‐Campos, José Luis
author_facet Reinoso‐Arija, Rocío
López‐Ramírez, Cecilia
Jimenez‐Ruiz, José Antonio
López‐Campos, José Luis
author_sort Reinoso‐Arija, Rocío
collection PubMed
description This is the first case of a patient taking aprepitant for a post‐acute COVID‐19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.
format Online
Article
Text
id pubmed-8449093
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84490932021-09-24 Effectiveness of aprepitant in post‐acute COVID19 syndrome Reinoso‐Arija, Rocío López‐Ramírez, Cecilia Jimenez‐Ruiz, José Antonio López‐Campos, José Luis Clin Case Rep Case Report This is the first case of a patient taking aprepitant for a post‐acute COVID‐19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome. John Wiley and Sons Inc. 2021-09-18 /pmc/articles/PMC8449093/ /pubmed/34567551 http://dx.doi.org/10.1002/ccr3.4646 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Reinoso‐Arija, Rocío
López‐Ramírez, Cecilia
Jimenez‐Ruiz, José Antonio
López‐Campos, José Luis
Effectiveness of aprepitant in post‐acute COVID19 syndrome
title Effectiveness of aprepitant in post‐acute COVID19 syndrome
title_full Effectiveness of aprepitant in post‐acute COVID19 syndrome
title_fullStr Effectiveness of aprepitant in post‐acute COVID19 syndrome
title_full_unstemmed Effectiveness of aprepitant in post‐acute COVID19 syndrome
title_short Effectiveness of aprepitant in post‐acute COVID19 syndrome
title_sort effectiveness of aprepitant in post‐acute covid19 syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449093/
https://www.ncbi.nlm.nih.gov/pubmed/34567551
http://dx.doi.org/10.1002/ccr3.4646
work_keys_str_mv AT reinosoarijarocio effectivenessofaprepitantinpostacutecovid19syndrome
AT lopezramirezcecilia effectivenessofaprepitantinpostacutecovid19syndrome
AT jimenezruizjoseantonio effectivenessofaprepitantinpostacutecovid19syndrome
AT lopezcamposjoseluis effectivenessofaprepitantinpostacutecovid19syndrome

Ejemplares similares